Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress.

    Modesti A, Bertolozzi I, Gamberi T, Marchetta M, Lumachi C, Coppo M, Moroni F, Toscano T, Lucchese G, Gensini GF, Modesti PA.

    Diabetes. 2005 Feb;54(2):394-401.PMID: 15677497 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.

    McWhinney CD, Dostal D, Baker K.

    J Mol Cell Cardiol. 1998 Apr;30(4):751-61.PMID: 9602424 [PubMed - indexed for MEDLINE]Related articles

    3.

    AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase.

    Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J.

    Hypertension. 2003 Aug;42(2):206-12. Epub 2003 Jul 7.PMID: 12847113 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.

    Shaw S, Wang X, Redd H, Alexander GD, Isales CM, Marrero MB.

    J Biol Chem. 2003 Aug 15;278(33):30634-41. Epub 2003 May 30.PMID: 12777386 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.

    Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB.

    Am J Physiol Renal Physiol. 2004 Apr;286(4):F653-9. Epub 2003 Dec 16.PMID: 14678947 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.

    Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC.

    Am J Physiol. 1998 Nov;275(5 Pt 1):C1216-23.PMID: 9814969 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Impaired angiotensin II-extracellular signal-regulated kinase signaling in failing human ventricular myocytes.

    Modesti PA, Serneri GG, Gamberi T, Boddi M, Coppo M, Lucchese G, Chiavarelli M, Bottai G, Marino F, Toz Gensini C, Franco Gensini G, Modesti A.

    J Hypertens. 2008 Oct;26(10):2030-9.PMID: 18806628 [PubMed - indexed for MEDLINE]Related articles

    8.

    Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.

    Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB.

    Kidney Int. 2002 May;61(5):1605-16.PMID: 11967010 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization.

    Calegari VC, Bezerra RM, Torsoni MA, Torsoni AS, Franchini KG, Saad MJ, Velloso LA.

    Endocrinology. 2003 Oct;144(10):4586-96. Epub 2003 Jun 26.PMID: 12960061 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I.

    Malhotra A, Kang BP, Cheung S, Opawumi D, Meggs LG.

    Diabetes. 2001 Aug;50(8):1918-26.PMID: 11473056 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction.

    Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H.

    Circ Res. 2000 Dec 8;87(12):1195-201.PMID: 11110778 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.

    Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM, Marrero MB.

    Diabetes. 2003 Sep;52(9):2381-8.PMID: 12941779 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

    Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, Hui RT, Lin M, Liang CC.

    Free Radic Biol Med. 2005 Jan 15;38(2):243-57.PMID: 15607907 [PubMed - indexed for MEDLINE]Related articles

    14.

    Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.

    Giani JF, Gironacci MM, Muñoz MC, Peña C, Turyn D, Dominici FP.

    Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1154-63. Epub 2007 May 11.PMID: 17496209 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Janus kinase 2 signaling in the angiotensin II-dependent activation of StAR expression.

    Clark BJ, Li J.

    Endocr Res. 2004 Nov;30(4):685-93.PMID: 15666812 [PubMed - indexed for MEDLINE]Related articles

    16.

    Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy.

    Foo RS, Siow RC, Brown MJ, Bennett MR.

    J Cell Physiol. 2006 Oct;209(1):1-7.PMID: 16826603 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.

    Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB.

    J Biol Chem. 1999 Nov 5;274(45):32382-6.PMID: 10542280 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes.

    Mascareno E, Beckles DL, Siddiqui MA.

    Vascul Pharmacol. 2005 Nov;43(5):327-35. Epub 2005 Nov 2.PMID: 16269269 [PubMed - indexed for MEDLINE]Related articles

    19.

    Angiotensin II blocks nicotine-mediated neuroprotection against beta-amyloid (1-42) via activation of the tyrosine phosphatase SHP-1.

    Shaw S, Bencherif M, Marrero MB.

    J Neurosci. 2003 Dec 3;23(35):11224-8.PMID: 14657181 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Jak2 tyrosine kinase mediates angiotensin II-dependent inactivation of ERK2 via induction of mitogen-activated protein kinase phosphatase 1.

    Sandberg EM, Ma X, VonDerLinden D, Godeny MD, Sayeski PP.

    J Biol Chem. 2004 Jan 16;279(3):1956-67. Epub 2003 Oct 9.PMID: 14551204 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data